Acid-base status alterations in adult patients with chronic renal failure
Article Sidebar
Main Article Content
Abstract
Introduction: the carrier of chronic renal failure can present various alterations of the basic acid state, being the metabolic acidosis the most frequent.
Objectives: to describe the demographic and clinical characteristics and alterations in the acid-base status of adult patients admitted with chronic renal failure in two hospitals in Paraguay.
Methodology: an observational, descriptive, cross-sectional design was applied. Adult subjects of both sexes, carriers of chronic renal failure, who attended the National Hospital (Itauguá) and the Military Hospital (Asunción) between April and November 2021 were included. Anthropometric, clinical and laboratory variables were measured at admission. The data was submitted to descriptive statistics with the Epi Info 7™ program. The study was approved by the Ethics Committee of the Universidad Privada del Este, Paraguay.
Results: 148 subjects were included, being 78 (52.7 %) men with a mean age of 58 ± 16 years and 70 (47.3 %) women with a mean age of 54 ± 17 years. The most frequent etiologies of chronic renal failure were diabetes mellitus and arterial hypertension (44.5 %). 12 subjects (8.1 %) with normal blood gases were detected. The most frequent alteration of the acid-base status was metabolic acidosis (87.2 %), with cases with normal anion gap predominating in this group.
Conclusions: the predominant acid-base status alterations in patients with chronic renal failure was metabolic acidosis with normal anion gap. It is suggested to apply the calculations of the compensatory mechanisms to arrive at the accurate diagnosis of these metabolic alterations.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Webster AC, Nagler E V, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238–52. doi: 10.1016/S0140-6736(16)32064-5
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’ Callaghan A, Lasserson DS, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765
Chen W, Levy D, Abramowitz M. Acid base balance and progression of kidney disease. Semin Nephrol. 2019;39(4):406–17. doi: 10.1016/j.semnephrol.2019.04.009.
Di Iorio BR, Di Micco L, Marzocco S, De Simone E, De Blasio A, Sirico ML, et al. Very low-protein diet (VLPD) reduces metabolic acidosis in subjects with chronic kidney disease: The “Nutritional light signal” of the renal acid load. Nutrients. 2017;9(1):69. doi: 10.3390/nu9010069
Siener R. Dietary treatment of metabolic acidosis in chronic kidney disease. Nutrients. 2018;10(4):512. doi: 10.3390/nu10040512
Carnauba RA, Baptistella AB, Paschoal V, Hübscher GH. Diet-induced low-grade metabolic acidosis and clinical outcomes: a review. Nutrients. 2017;9(6):538. doi: 10.3390/nu9060538
Souto G, Donapetry C, Calviño J, Adeva MM. Metabolic acidosis-induced insulin resistance and cardiovascular risk. Metab Syndr Relat Disord. 2011;9(4):247–53. doi: 10.1089/met.2010.0108
Kraut JA, Madias NE. Treatment of acute metabolic acidosis: A pathophysiologic approach. Nat Rev Nephrol. 2012;8(10):589–601. doi: 10.1038/nrneph.2012.186
Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S. Serum bicarbonate and mortality in adults in NHANES III. Nephrol Dial Transplant. 2013;28(5):1207–13. doi: 10.1093/ndt/gfs609
Paniagua Muñoz L. Trastornos ácido-base: fisiopatología, etiología y abordaje. Rev Med Costa Rica Centroamer. 2016;73(618):83–6. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2016/rmc161p.pdf
Hamilton PK, Morgan NA, Connolly GM, Maxwell AP. Understanding acid-base disorders. Ulster Med J. 2017;86(3):161–6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849971/pdf/umj-86-03-161.pdf
Kraut JA, Kurtz I. Treatment of acute non-anion gap metabolic acidosis. Clin Kidney J. 2015;8(1):93–9. doi: 10.1093/ckj/sfu126
Meza García M. Disturbios del estado ácido-básico en el paciente crítico. Acta méd. peruana. 2011;28(1):46–55. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1728-59172011000100008
Alcázar Arroyo R, Albalate Ramón M, De Sequera Ortiz P. Trastornos del metabolismo ácido-base [Internet]. En: Lorenzo V, López Gómez JM (Eds). Nefrología al Día. 2019. p. 221–42. Disponible en: https://www.nefrologiaaldia.org/es-articulo-trastornos-del-metabolismo-acido-base-403.
Zheng CM, Liu WC, Zheng JQ, Liao MT, Ma WY, Hung KC, et al. Metabolic acidosis and strong ion gap in critically ill patients with acute kidney injury. Biomed Res Int. 2014;2014:819528. doi: 10.1155/2014/819528
Jung B, Martinez M, Claessens YE, Darmon M, Klouche K, Lautrette A, et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care. 2019;9:92. doi: 10.1186/s13613-019-0563-2
Vera Carrasco O. Trastornos del equilibrio ácido-base. Rev Med La Paz. 2018;24(2):65–76. Disponible en: http://www.scielo.org.bo/pdf/rmcmlp/v24n2/v24n2_a11.pdf
Ferreira JP. Acidosis metabólica. Conceptos actuales. Rev Pediátrica Elizalde. 2015;6(1–2):1–54. Disponible en: https://www.apelizalde.org/revistas/2015-1-2-ARTICULOS/RE_2015_1-2_AO_3.pdf
Saínz Menéndez B. Alteraciones del equilibrio acido básico. Rev Cuba Cir. 2006;45(1):1–22. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932006000100011
Caravaca-Fontán F, Díaz-Campillejo R, Valladares J, López Arnaldo C, Barroso S, Luna E, et al. Acidosis metabólica en la enfermedad renal crónica: dificultades para una corrección adecuada. Nefrología. 2020;40(3):328–35. doi: 10.1016/j.nefro.2019.09.006
Berend K. Review of the diagnostic evaluation of normal anion Gap metabolic acidosis. Kidney Dis. 2017;3(4):149–59. doi: 10.1159/000479279
Fores-Novales B, Diez-Fores P, Aguilera-Celorrio L. Assessment of acid-base balance. Stewart's approach. Rev Esp Anestesiol Reanim. 2016;63(4):212–9. doi: 10.1016/j.redar.2015.04.004
Kraut JA, Madias NE. Differential diagnosis of nongap metabolic acidosis: value of a systematic approach. Clin J Am Soc Nephrol. 2012;7(4):671–9. doi: 10.2215/CJN.09450911
Pham A, Xu L, Moe O. Drug-induced metabolic acidosis. F1000Research. 2015;4:1460. doi: 10.12688/f1000research.7006.1
Peralta R, Gamarra Fleitas F, Gómez Fernández MN, Vaesken Rojas J, Frutos López RD, Galeano Vera SM. Características clínicas de la anemia en la enfermedad renal crónica de pacientes del Hospital Nacional en 2018. Rev virtual Soc Parag Med Int. 2019;6(1):11–20. doi: 10.18004/rvspmi/2312-3893/2019.06(01)11-020
García Salinas HA, Barreto RS, Gavilán Herreros JA, Insfrán Echauri EM, Sisa Ferreira CG, Santa Cruz Segovia FV. Detección de enfermedad renal crónica oculta en personas del Bañado Sur de Asunción. Rev virtual Soc Parag Med Int. 2015;2(1):23–30. doi: 10.18004/rvspmi/2312-3893/2015.02(01)23-030
Wang F, Ao G, Wang Y, Liu F, Bao M, Gao M, et al. Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis. Ren Fail. 2021;43(1):1394–407. doi: 10.1080/0886022X.2021.1986408
Gaggl M, Cejka D, Plischke M, Heinze G, Fraunschiel M, Schmidt A, et al. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: Study protocol for a randomized controlled trial (SoBic-Study). Trials. 2013;14:196. doi: 10.1186/1745-6215-14-196